Preoperative Mindfulness: Minimally Invasive Hysterectomy

Sponsor
Montefiore Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05157490
Collaborator
(none)
72
2
4

Study Details

Study Description

Brief Summary

This is a randomized control trial investigating the effects of a preoperative mindfulness intervention on postoperative pain, quality of recovery and stress scores in women undergoing minimally invasive hysterectomy. The mindfulness intervention will be delivered via the application Headspaceā„¢. The primary outcome will be pain scores measured on postoperative day one. Secondary outcomes will include quality of recovery scores and perceived stress scores measured on postoperative days 1 and 7, amount of opioid consumed, and dose response between number of sessions and/or numbers of minutes of meditation performed on pain and quality of recovery scores. We hypothesize that mindfulness practiced in the form of meditation delivered via an internet application will lead to reduced pain scores on postoperative day 1.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Mindfulness training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Preoperative Mindfulness In Patients Undergoing Minimally Invasive Hysterectomy: A Randomized Controlled Trial
Anticipated Study Start Date :
Sep 30, 2022
Anticipated Primary Completion Date :
Dec 30, 2022
Anticipated Study Completion Date :
Jan 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Mindfulness training

Completion of guided meditations in the preoperative time period, at least 3 sessions per week, leading up to surgery

Behavioral: Mindfulness training
Guided meditations in the preoperative time period, at least 3 sessions per week, leading up to surgery

No Intervention: Control

Outcome Measures

Primary Outcome Measures

  1. Pain score [1 day]

    Postoperative day 1 pain score using Numeric Pain Rating Scale

Secondary Outcome Measures

  1. QOR-15 score [7 days]

    Quality of Recovery Score

  2. PSS-10 score [7 days]

    Perceived Stress Scale

  3. Opioid consumption [7 days]

    number of opioid tablets used postoperatively

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Undergo minimally invasive hysterectomy

  • Fluency in English

  • Access to a device capable of running the Headspace application (smart phone or computer)

Exclusion Criteria:
  • Minors

  • Inability to access Headspace app

  • inability to complete surveys in English

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Montefiore Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Montefiore Medical Center
ClinicalTrials.gov Identifier:
NCT05157490
Other Study ID Numbers:
  • 2020-12609
First Posted:
Dec 15, 2021
Last Update Posted:
Jul 26, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 26, 2022